Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Statement from BICO regarding counterclaims in patent lawsuit by Organovo against group company CELLINK

Due to recently filed counterclaims in patent lawsuit by Organovo, Inc., (“Organovo”) to the Federal Court in Delaware, BICO Group AB (“BICO”) releases the following statement to explain the background and context. BICO, CELLINK and all our group companies respect valid intellectual property and believe that Organovo’s patent claims at issue are invalid, not infringed, or both. We look forward to coming to a favourable resolution and will provide updates as they become available. The products concerned are expected to account for approximately 1-2 percent of the Group's estimated

#22-12 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Scandinavian ChemoTech continues its focus on Animal Care in the US and prepares for one of the most important trade fairs

The company's CEO plans to conduct a 10-day tour in the United States including being present during the VMX (Veterinary Meeting and Expo), one of the most important trade fairs for veterinary medicine in the United States.Unless new restrictions or obstacles arise, the Company's CEO, Mohan Frick, will carry out his first trip to the United States since the beginning of the pandemic. During this time, the company has established a number of strategic contacts which we hope to be able to advance further with during these days. The Company continues to a have great outlook on its Animal Care

The claim against local procurement partner in Germany has been ruled in favour of Kamux ‒ the decision will not have immediate effects on financial result

Kamux Corporation       Inside Information         January 11, 2022 at 16:30 (EET)      The claim against local procurement partner in Germany has been ruled in favour of Kamux ‒ the decision will not have immediate effects on financial result Kamux has received the decision of the Stuttgart District Court dated January 10, 2022 regarding legal proceedings against local procurement partner initiated by Kamux’s German subsidiary Kamux Auto GmbH. In the process, Kamux Auto GmbH demanded refund of payments from the procurement partner related to purchasing contracts. The district

Wyld Networks and partners form global consortium to advance IoT network coverage

Virtual satellite network operator Wyld Networks today announced it has partnered with Eutelsat Communications, Senet, and TrakAssure, forming a consortium to bring integrated and interoperable terrestrial and satellite LoRaWAN® IoT connectivity to customers across the globe.Through platform integrations, innovative sensor and hardware design, collaborative service delivery, and compelling pricing, the companies are initially targeting the global supply chain, including container logistics and related asset tracking, as the first application. End-to-end managed network services delivered

Offering state-of-the-art imaging technology for every dental practice in Poland

Two entrepreneurs found out that many smaller dental practices in Poland are not able to invest in the latest digital imaging technology. To fight this so-called digital exclusion, they decided to establish a chain of full-service radiology centres with state-of-the-art imaging equipment. In three years, the owners have opened three easily accessible locations to which Polish dental practices can send their patients for all their imaging needs. Marcin Gielec and Marcin Szydlowski met at an MBA course for entrepreneurs in 2017 and immediately noticed they shared similar views on

Beijer Ref acquires leading HVAC distributor in Croatia

As of today, Beijer Ref has acquired 80% of the shares in Deltron, with an option to acquire the remaining shares. The company is headquartered in Split (Croatia) and has an annual turnover of approximately SEK 400 million, with a good profitability.Deltron was founded in 1995 and their main business consists of air conditioning equipment for commercial and private use. In 2014, Deltron established a subsidiary in Sarajevo (Bosnia and Herzegovina) that in recent years has experienced strong and profitable sales growth. Beijer Ref already has a minor presence in Croatia and will, through

The Chaotic Law That Solves Nothing

As the new EU regulations on tattoo ink have come into effect, tattoo artists are uncertain about the future of tattoos. False rumors about the availability and unavailability of certain inks and colours are abundant.Meanwhile, lawmakers in both the UK, the US and other parts of the world are considering proposals similar to the EU REACH legislation. Confusion About Legal Inks New inks are slowly appearing on the market in accordance with the new regulations. But some crucial questions remain. In the early days after the new law came into force, a persistent rumor made the news. It

Tryg Norway is launching a tailored EV insurance using AI optimized premiums on the world’s largest EV market

Greater Than (GREAT.ST), the insurtech using AI for pricing insurance based on real-time analyses of drivers’ accident probability, has in partnership with the Tryg A/S now tailored Tryg Sidekick to include electric vehicles. As Norway is the world's largest market for EV's, the insurance offering addresses an ever-growing need for dynamic, fairer, and more transparent premiums also for drivers of electric vehicles.Tryg's insurance offering Sidekick is tailored for younger drivers aged 18 to 30 years old. The offering is based on Greater Than's AI technology, making it possible to price

Nakilat Partners with ABS to Develop Decarbonization Strategy

Nakilat Has Worked with ABS to Develop a Decarbonization Plan and Evaluated Performance Against UN Sustainable Development Goals(DOHA) Nakilat, one of the world’s largest LNG shipping operators, has partnered with ABS to develop an industry-leading decarbonization strategy. Over the past months, Nakilat’s project team has worked closely with ABS sustainability specialists to map out decarbonization pathways for the company’s fleet of 69 LNG carriers and four Very Large LPG Gas Carriers. These efforts come as part of Nakilat’s drive to become a global maritime sustainability leader.

Invitation to conference call and webcast presentation of Dometic’s Q4 and year-end report 2021

Dometic Group AB (publ) will publish its Q4 and year-end report 2021 at around 08.00 CET on Thursday, January 27, 2022. On the same day at 10.00 CET, Dometic will host a conference call and webcast to present the results. The presentation can be followed live via webcast and will also be available afterwards. The presentation will be held in English. The report and the presentation material will be available on Dometic’s website, https://www.dometicgroup.com/en/investors 

Enviro to take part in Carnegie’s seminar Circular economy & Electric transportation

Enviro will be one of the companies to take part in a two-day cleantech seminar that investment bank Carnegie will initiate today on the theme of circular economy and electric transportation. Alf Blomquist, Chairman of the Board of Enviro, will hold a presentation where he will talk about the great opportunities that the company sees for its proprietary recycling technology and the steps that are now being made to industrialise and commercialise the patented technology.The seminar is entitled “Circular economy & Electric transportation” and more than 20 Nordic companies will take part

Audientes expands distribution network to private hospitals, healthcare centers and highstreet points of sale in New Delhi through new partnership

Audientes A/S and Priority Hearing, India, today announce a Collaboration Agreement for the sale of Audientes’ self-fitting hearing aid, Ven™, in Priority Hearing’s 14 points of sale that include private hospitals, healthcare centers and highstreet retail clinics throughout New Delhi.Audientes has entered into another Collaboration Agreement in India. Today’s announcement of a Collaboration Agreement with Priority Hearing and its 14 associated points of sale throughout the megacity of New Dehli brings the total of Audientes partners to six thus enabling the hearing device Ven to reach more

FREYR Battery and Aleees to Pursue LFP Cathode Manufacturing Joint Venture

New York, Oslo and Luxembourg, January 11, 2022, FREYR Battery (NYSE: FREY) (“FREYR”), a developer of clean, next-generation battery cell production capacity, and Aleees (TWSE: 5227), a producer of lithium iron phosphate (“LFP”) cathode materials for batteries, have signed a Head of Terms agreement to pursue a Joint Venture (“JV”) with the ambition to establish an LFP cathode plant in the Nordic region. The joint venture partners will seek to commence production in 2024, coinciding with the anticipated ramp-up of operations from FREYR’s first Gigafactory in Mo i Rana, Norway. The

Scandinavian ChemoTech receives approval from the US Patent Office

Scandinavian ChemoTech AB announces today that the Company has received approval from the US Patent Office for its innovation for the treatment of pain caused by metastases in the spine and skeleton. This innovation is also applicable to the treatment of deep-seated tumours, which is another of the Company's development projects.The patent is based on the same innovation that was approved in Europe in July 2021 and includes a specially developed electrode as well as unique dynamic properties. These functions are already implemented in the TSE platform and are intended to treat tumours

Nordic Mining ASA: Additional information on Convertible Loan

Nordic Mining ASA (“Nordic Mining” or the “Company”) provides additional information in relation to the previously announced Convertible Loan of NOK 132.5 million. Subject to any adjustments disclosed in the key terms and conditions enclosed the previous release the conversion price shall be NOK 3.355 per share. NOK 3.355 per share is the 20 days Volume Weighted Average Price (“VWAP”) as of the stock market close on 10 January 2022. This share price represents a premium of 2% to the 30 days VWAP of NOK 3.288 per share and a discount of 16% to stock market close on 10 January 2022 of NOK

NIB lends to new wind farms in Estonia and Lithuania

The Nordic Investment Bank (NIB) and Estonian renewable energy producer Enefit Green AS have agreed on a EUR 80 million loan for a period of 12 years to co-finance wind power projects in Lithuania and Estonia.Enefit Green is currently constructing the two wind farms Šilale II and Akmene in Lithuania. Combined, the two wind farms will add 118 megawatts of renewable electricity generation capacity to the Baltic region. The wind farms are planned to become operational by the end of 2023. The Akmene wind farm (75 MW) will then become the company’s largest wind farm. Enefit Green is also

Prostatype® P-score and prognostic evaluation in Prostate cancer to be presented at AUA, one of the world’s leading Urology events

-Results of the study from Uppsala University Hospital (“Akademiska”) selected to present during American Urology Association annual meeting 2022, taking place in New Orleans on May 13-16[th].The American Urology Association congress 2022 is one of the largest and most important gathering of Urologists in the world, and Prostatype Genomics is very proud to share that one of our Prostatype® clinical validation studies, whose preliminary results were first shared in August 2021, have been selected for presentation at the congress. Fredrik Persson, CEO of Prostatype Genomics, comments; “We

Norway Royal Salmon (NRS): Combination of SalmoNor and Norway Royal Salmon ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR PURCHASE ANY OF THE SECURITIES DESCRIBED HEREIN.Norway Royal Salmon ASA («NRS») and NRS Farming AS has today entered into a Share Purchase Agreement for NRS Farming AS to acquire 100% of the shares in SalmoNor from NTS ASA(“NTS”) (the “Transaction”). The agreement follows the stock exchange

Idogen adds Norway for its clinical phase 1/2a study and submits an application for approval for its cell therapy treatment IDO 8 to the Norwegian Medicines Agency NoMA

Idogen AB announces today that in addition to its Swedish application, it has also sub-mitted an application to the Norwegian Medicines Agency, NoMA, to be able to begin its clinical phase 1/2a study of the company's most advanced cell therapy treatment IDO 8 in Norway. IDO 8 aims to create tolerance for factor VIII and thus enable ongoing substitu-tion treatment with coagulation factor VIII - a life-saving drug treatment for hemophilia A against which many patients develop antibodies. The aim of the planned phase 1/2a study, which was designed in close dialogue with clinical experts and

Smoltek appoints Farzan Ghavanini as new Chief Technology Officer (CTO) with effect from 1 April 2022

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has recruited Farzan Ghavanini, with solid experience from leading positions in technology development at innovative listed companies and a research background in nanotechnology, for the position as the company's new Chief Technology Officer (CTO). He will assume the position on April 1 2022 and succeed Peter Enoksson, who has been acting CTO for Smoltek since 20 September 2021.Farzan Ghavanini most

DecideAct closes contract with the first customer in the surgical service sector

DecideAct has signed a contract with Klíníkin Ármúla – Iceland’s only privately operated surgical service with a license to operate an inpatient department. The clinic will use DecideAct’s digital tool to monitor the strategic progress and make sure that the organization’s strategic goals are met.We are pleased to announce that DecideAct now enters a new business field as we have signed with the first customer in the surgical service sector and are welcoming Klíníkin Ármúla as a DecideAct customer. Klíníkin Ármúla is a modern medical center where specialists work together to deliver safe,

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 500,000,000.Start date:                   13 January 2022 Maturity:                     14 February 2022 Coupon:                      0.76 % Organised by:             Nordea Markets             Orkla ASA Oslo, 11 January 2022     Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 11.01.2022, 12.30 PMManagers' transactionsViking Line Abp has today January 11:th, 2022 received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person closely associated with a person discharging managerial responsibilities in Viking Line Abp.  Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Maelir ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial

There are no items matching the current filter
There are no more items matching the current filter
Back to top